Ultragenyx Pharmaceutical Inc. - RARE
About Gravity Analytica
Recent News
- 09.23.2025 - Bank of America Global Healthcare Conference
- 09.23.2025 - Bank of America Global Healthcare Conference
- 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conferenc
- 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conferenc
- 09.08.2025 - Ultragenyx Announces Positive Longer-term Data from Phase 3 Study of DTX401 AAV Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)
- 09.08.2025 - Ultragenyx Announces Positive Longer-term Data from Phase 3 Study of DTX401 AAV Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)
- 09.08.2025 - Ultragenyx Announces Positive Longer-term Data from Phase 3 Study of DTX401 AAV Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)
- 09.04.2025 - Cantor Global Healthcare Conference 2025
- 09.04.2025 - Cantor Global Healthcare Conference 2025
- 08.29.2025 - Ultragenyx to Participate at Investor Conferences in September